×
ISpecimen Total Liabilities 2020-2025 | ISPC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
ISpecimen total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
ISpecimen Total Liabilities 2020-2025 | ISPC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
ISpecimen total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.1B
CVS Health (CVS)
$76.8B
Elevance Health (ELV)
$65.1B
Cencora (COR)
$56.3B
DiDi Global (DIDIY)
$25.7B
Labcorp Holdings (LH)
$22.2B
Natera (NTRA)
$19B
BioMerieux (BMXMF)
$17.7B
EUROFINS SCIENT (ERFSF)
$15.9B
ICON (ICLR)
$15.1B
CochLear (CHEOY)
$13.4B
Solventum (SOLV)
$12.9B
Medpace Holdings (MEDP)
$12.6B
Revvity (RVTY)
$12.2B
Viatris (VTRS)
$11B
Avantor (AVTR)
$9.7B
Sonic Healthcare (SKHHY)
$9.1B
Charles River Laboratories (CRL)
$8.7B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$7.5B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5.1B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.5B
Surgery Partners (SGRY)
$2.7B
Organon (OGN)
$2.7B
Concentras Parent (CON)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
GeneDx Holdings (WGS)
$2.3B
Progyny (PGNY)
$2B